Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with…

Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis

Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis#Remegen…

Autonomix to begin U.S. clinical studies for FDA approval

Autonomix to begin U.S. clinical studies for FDA approval#Autonomix #U.S #clinical #studies #FDA #approval

Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns

Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns #Takeda #amp #Protagonist #Rusfertide #Clinical #Success #Bolsters…

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical &…

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on…

Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive

Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive #Theravance #Biopharma #Clinical #Progress #Attractive

Sonida Senior Living Advances Clinical Excellence with August Health

Sonida Senior Living Advances Clinical Excellence with August Health#Sonida #Senior #Living #Advances #Clinical #Excellence #August #Health

Y-mAbs Therapeutics: Finding Direction Through The Murk Of Clinical Trials

Y-mAbs Therapeutics: Finding Direction Through The Murk Of Clinical Trials #YmAbs #Therapeutics #Finding #Direction #Murk #Clinical…

Lindus Health raises $55M to ‘fix the broken clinical trial industry’

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round…

AstraZeneca: Diverse Clinical Pipeline Meeting Future Demand, In Undervalued Sector (NASDAQ:AZN)

Albert Anthony is the pen name / stage name of markets analyst, contributor & host of…

Grove cuts clinical trial enrollment time with AI

Tran Le was an engineering student at Stanford University when she tried to enroll in a…

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory…